Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
48035
CAS Number:
20235-78-3
2-Thiouridine
Purity:
≥ 98 % (HPLC)
Synonym(s):
1-β-D-ribofuranosyl-2-thiouracile, 1-β-D-ribofuranosyl-2-thioxo-2,3-dihydro-4(1 H -pyrimidinone
Documents
$165.00 /100 mg
Taille
Request Bulk Quote
Product Information

Conserver sous gaz inerte

Synonyms
1-β-D-ribofuranosyl-2-thiouracile, 1-β-D-ribofuranosyl-2-thioxo-2,3-dihydro-4(1 H -pyrimidinone
CAS Number
20235-78-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C9H12N2O5S
Molecular Weight
260.26
MDL Number
MFCD03788697
Melting Point
214 - 216 °C
Appearance
Poudre blanche à jaune clair
Conditions
Conserver entre 2 et 8 °C
General Information
Synonyms
1-β-D-ribofuranosyl-2-thiouracile, 1-β-D-ribofuranosyl-2-thioxo-2,3-dihydro-4(1 H -pyrimidinone
CAS Number
20235-78-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C9H12N2O5S
Molecular Weight
260.26
MDL Number
MFCD03788697
Melting Point
214 - 216 °C
Appearance
Poudre blanche à jaune clair
Conditions
Conserver entre 2 et 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

2-Thiouridine is widely utilized in research focused on:

  • Nucleic Acid Research: It is used as a building block in the synthesis of modified RNA molecules, enhancing the stability and functionality of RNA in various applications.
  • Antiviral Drug Development: Researchers explore its potential as a therapeutic agent against viral infections, particularly in the development of drugs targeting RNA viruses.
  • Biochemical Assays: It serves as a substrate in enzymatic assays to study RNA modifications and the activity of RNA-modifying enzymes, providing insights into cellular processes.
  • Gene Expression Studies: The compound is employed in experiments to investigate the effects of RNA modifications on gene expression and regulation, aiding in understanding gene function.
  • Pharmaceutical Formulations: It is being explored for its potential in drug formulations, particularly in enhancing the delivery and efficacy of RNA-based therapeutics.

Citations